Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Personalis Inc
(NQ:
PSNL
)
3.450
+0.590 (+20.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis Inc
< Previous
1
2
3
4
5
6
Next >
Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023
May 30, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer
May 16, 2023
From
Personalis, Inc.
Via
Business Wire
Analyst Ratings for Personalis
May 04, 2023
Via
Benzinga
Recap: Personalis Q1 Earnings
May 03, 2023
Via
Benzinga
Personalis Reports First Quarter 2023 Financial Results
May 03, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis's Return On Capital Employed Insights
February 28, 2023
Via
Benzinga
Earnings Outlook For Personalis
February 22, 2023
Via
Benzinga
Cancer Genomics-Focused Personalis To Reduce Nearly One-Third Of Its Workforce
January 19, 2023
Via
Benzinga
Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer
May 02, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce First Quarter 2023 Financial Results
April 19, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference
April 05, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study
April 05, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023
March 22, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
March 07, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Appoints Christopher Hall as Chief Executive Officer
March 02, 2023
From
Personalis, Inc.
Via
Business Wire
Toll Brothers To Rally 25%? Here Are 10 Other Analyst Forecasts For Friday
February 24, 2023
Oppenheimer boosted the price target for Universal Display Corporation (NASDAQ: OLED) from $150 to $160. Oppenheimer analyst Martin Yang maintained an Outperform rating on the stock. Universal Display...
Via
Benzinga
Personalis Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Fourth Quarter and Full Year 2022 Financial Results
February 09, 2023
From
Personalis, Inc.
Via
Business Wire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Personalis to Participate at Upcoming Investor Conferences
February 06, 2023
From
Personalis, Inc.
Via
Business Wire
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
February 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
February 06, 2023
Via
Benzinga
Why Personalis Shares Are Trading Higher Today
February 03, 2023
Via
Benzinga
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
February 03, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue
January 04, 2023
From
Personalis, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 26, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 22, 2022
Thursday's session saw 329 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 21, 2022
On Wednesday, 152 stocks made new 52-week lows.
Via
Benzinga
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2022
From
Personalis, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.